Top Markets
Coin of the day
AB Science S.A. AB Science S.A.

AB Science S.A.

AB
Rank in Stocks #24492
AB Science S.A. is a pharmaceutical company dedicated to the discovery,... AB Science S.A. is a pharmaceutical company dedicated to the discovery, development, and commercialization of protein kinase inhibitors for applications in both human and animal health. Its primary drug candidate, masitinib, a tyrosine kinase inhibitor, is currently undergoing late-stage (Phase III) clinical investigations for a range of serious conditions including prostate cancer, pancreatic cancer, amyotrophic lateral sclerosis (ALS), multiple sclerosis, Alzheimer's disease, severe asthma, and mastocytosis. Additionally, masitinib is being evaluated in Phase II clinical trials for the treatment of Covid-19. The company's pipeline also features AB8939, a synthetic microtubule destabilizer aimed at treating acute myeloid leukemia, and AB20001, which is in Phase 2 trials to assess the safety and efficacy of masitinib combined with isoquercetin in hospitalized patients experiencing moderate to severe COVID-19. Masitinib is sold under the brand name Masivet in the European market. AB Science S.A. was founded in 2001 and is based in Paris, France.
Share Price
$0.82200553
Market Cap
$60.21M
Change (1 day)
0.00%
Change (1 year)
-45.55%
Country
FR
Trade AB Science S.A. (AB)

Category

Stock price history for AB Science S.A. (AB)
Highest end of day price: $0.89 on 2026-08-01

Lowest end of day price: $16.75 on 2010-04-01
Stock price history of AB Science S.A. from 2010 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -8.97%
2025 63.64%
2024 -74.78%
2023 -54.37%
2022 -42.31%
2021 -20.56%
2020 194.79%
2019 39.37%
2018 -58.53%
2017 -24.07%
2016 -8.24%
2015 -2.05%
2014 -27.26%
2013 -13.13%
2012 239.91%
2011 -35.27%
2010 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
$171.67 -
DE
$163.63 27.51%
DE
$37.61 23.06%
JP
$223.11 32.17%
CH
$20.99 11.74%
IN